Guanhao Biotech Co.,Ltd. (SHE:300238)

China flag China · Delayed Price · Currency is CNY
15.87
+0.20 (1.28%)
Mar 10, 2026, 10:20 AM CST
19.68%
Market Cap 4.15B
Revenue (ttm) 392.83M
Net Income (ttm) 26.30M
Shares Out 265.16M
EPS (ttm) 0.10
PE Ratio 158.37
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,813,900
Average Volume 5,271,840
Open 14.90
Previous Close 15.67
Day's Range 14.90 - 15.93
52-Week Range 10.17 - 19.98
Beta 0.33
RSI 49.94
Earnings Date Mar 26, 2026

About Guanhao Biotech

Guanhao Biotech Co.,Ltd. develops, manufactures, and sells regenerative medicines and life sciences products primarily in China. It offers NormalGEN, a dura repair patch; GrandNeuro, a dura repair patch; ThormalGEN, a surgical patch; DermalGEN, a wound dressing product; IREAL breast patch; and Youvision corneal graft, as well as license in intraocular lenses. The company also provides Biological dura, a spinal patch; Type B dura, a spinal patch; Sterile Bio Wound Membrane; Ario Mesh; Thoracic Surgery Repair Diaphragm; and Cympic Benvimod Cream ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 530
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300238
Full Company Profile

Financial Performance

In 2024, Guanhao Biotech's revenue was 377.48 million, a decrease of -6.60% compared to the previous year's 404.18 million. Earnings were 27.42 million, a decrease of -11.57%.

Financial Statements

News

There is no news available yet.